Skip to main content
OpenTrials

Clinical trial condition

Emphysema

Explore clinical trials studying Emphysema. Study availability and eligibility vary by location and protocol.

80 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Emphysema trial results

Completed

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

NCT01684410

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +11 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • National Jewish Hospital Denver, Colorado, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
  • UNC at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

Genomic Research in Alpha-1 Antitrypsin Deficiency

NCT01832220

Conditions
AATD, Alpha 1 Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Arizona Health Sciences Center Tucson, Arizona, United States
  • University of California - San Francisco San Francisco, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults

NCT00295061

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • St Lukes-Roosevelt Hospital Center, New York New York, United States
View Trial Details
Completed

The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency

NCT00301366

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • St Lukes-Roosevelt Hospital Center, New York New York, United States
View Trial Details
Completed

Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)

NCT01419158

Conditions
Alpha-1 Antitrypsin Deficiency, Chronic Disease, Chronic Obstructive Pulmonary Disease, +14 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida (Gainesville) Gainesville, Florida, United States
  • University of Florida (Jacksonville) Jacksonville, Florida, United States
View all 19 locations
View Trial Details
Completed

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

NCT00460096

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida School of Medicine Gainesville, Florida, United States
  • The University of Texas Health Center at Tyler Tyler, Texas, United States
View Trial Details
Terminated

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

NCT04204252

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University Hospital (UZ) Leuven Leuven, Belgium
  • Tays Central Hospital Tampere, Finland
  • Beaumont Hospital Dublin, Ireland
  • Leiden University Medical Center (LUMC) Leiden, ZA, Netherlands
View Trial Details

Related conditions